πŸ‡ΊπŸ‡Έ FDA
Patent

US 8207114

Targeted therapeutic proteins

granted A61KA61K38/30A61K38/47

Quick answer

US patent 8207114 (Targeted therapeutic proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/30, A61K38/47, A61K47/551, A61K47/6425